Bland, A., Chuah, E., Meere, W. and Ford, T. J. (2024) Targeted therapies for microvascular disease. Cardiology Clinics, 42(1), pp. 137-145. (doi: 10.1016/j.ccl.2023.07.002) (PMID:37949535)
Full text not currently available from Enlighten.
Abstract
Coronary microvascular dysfunction (CMD) is a common cause of ischemia but no obstructive coronary artery disease that results in an inability of the coronary microvasculature to meet myocardial oxygen demand. CMD is challenging to diagnose and manage due to a lack of mechanistic research and targeted therapy. Recent evidence suggests we can improved patient outcomes by stratifying antianginal therapies according to the diagnosis revealed by invasive assessment of the coronary microcirculation. This review article appraises the evidence for management of CMD, which includes treatment of cardiovascular risk, antianginal therapy and therapy for atherosclerosis.
| Item Type: | Articles |
|---|---|
| Status: | Published |
| Refereed: | Yes |
| Glasgow Author(s) Enlighten ID: | Ford, Thomas |
| Authors: | Bland, A., Chuah, E., Meere, W., and Ford, T. J. |
| College/School: | College of Medical Veterinary and Life Sciences > School of Cardiovascular & Metabolic Health |
| Journal Name: | Cardiology Clinics |
| Publisher: | Elsevier |
| ISSN: | 0733-8651 |
| ISSN (Online): | 1558-2264 |
| Published Online: | 08 November 2023 |
University Staff: Request a correction | Enlighten Editors: Update this record
Deposit and Record Details
Deposit and Record Details